2CHOBANIAN A V,BAKRIS G L,BLACK H R,et al.The seventh report of the joint national committee on prevention,detection,evaluation and treatment of high blood pressure:the JNC-7 report[J].JAMA,2003,289(22):2560-2572.
3Guidelines Committee.2003 European Society of Hypertension European Society of Cardiology guidelines for the management of arterial hypertension[J].J Hypertens,2003,21:1021-1053.
4ANON.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)[J].JAMA,2002,288(23):2981 -2997.
5JOUNELA A J,LILJA M,LUMMEJ,et al.Relation between low dose of hydrochlorothiazide,antihypertensive effect and adverse effects[J].Blood Press,1994,3:231-235.
6POOLE-WILSON PA,LABSEN J,KIRWAN B A,et al.Effect of long acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial):randomized controlled trial[J].Lancet,2004,364 (9437):849 -857.
7WING L M,REID C M,RYAN P,et al.A comparison of outcomes with angiotensin converting enzyme inhibitors and diuretics for hypertension in the elderly[J].N Engl J Med,2003,348(7):583 -592.
8JULIUS S,KJELDSEN S E,WEBER M,et al.Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine:the VALUE randomised trial[J].Lancet,2004,363:2022 -2031.
9KOSTIS J B,PACKER M,BLACK H R,et al.Omapatrilat and enalapril in patients with hypertension:the Omapatrilat Cardiovascular Treatment vs.Enalapril (OCTAVE) trial[J].Am J Hypertens,2004,17 (2):103-111.
10WILLIAMS G H,BURGESS E,KOLLOCH R E,et al.Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension[J].Am J Cardiol,2004,93 (8):990-996.
3WHO-ISH,Hypertension Guidelines Committee. 1990 world health organization-international society of hypertension guidelines for the management of hypertension[J].Journal of Hypertension,2011,(09):151-183.
